Template:Butalbital/aspirin/caffeine/codeine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 36: | Line 36: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule labels and packages|Labels and Packages]] | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Butalbital, aspirin, cafeine, and codeine | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | ||
|- | |- | ||
|} | |} | ||
Latest revision as of 00:14, 12 February 2014
| Butalbital/aspirin/caffeine/codeine |
|---|
| ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Butalbital, aspirin, cafeine, and codeine |
| ClinicalTrials.gov |